Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 3.2 -1.5 - 3

Motif Bio Share Discussion Threads

Showing 8926 to 8946 of 8950 messages
Chat Pages: 358  357  356  355  354  353  352  351  350  349  348  347  Older
DateSubjectAuthorDiscuss
18/1/2021
09:26
Are you complaining because a shareholder who asked a question got an answer and they didn't cc. in all those who didn't ask?
bi11y ray va1entine
15/1/2021
11:58
So if Robblertwo has been told that the General Meeting and vote dont have to happen by the end of the month per his post on LSE under the heading Walbrook....why aren't shareholders told this fairly valuable piece of information given its our money who have allowed this lot to take a salary they so far have done nothing to deserve? If Walbrook know that the 28th January deadline can be extended without Motif losing its listing how do we, the people who have actually invested money IN the company and not OUT like Walbrook, Peel Hunt, the BOD etc NOT KNOW? Again its staggering to see how this continues to be run with people and companies getting paid HUNDREDS of THOUSANDS OF DOLLARS OF OUR MONEY but tell us nothing
scottdavid70
15/1/2021
09:54
I see Walbrook are pushing the line we dont need a General Meeting to be announced yet. Sp how exactly are shareholders going to be able to vote on the potential RTO with just 10 business days left, no information on what the RTO looks like for current shareholders and the RTO in their own words needs to be completed by the 28th. Thats Grade one mathematics there unless they want to spell it out in plain English why things are different than what is stated in the AIM rules and by them. Doubt there is little chance of that but the new company BIOMARK PHARMACEUTICALS Lumsden has shuffled off too will be no doubt getting some enlightening comments by Motifs long suffering ordinary hard working shareholders on Social Media and Linkedln soon enough with this sorry saga ends
scottdavid70
14/1/2021
22:06
While reminisce about Motif and the work Lumsdne did...by the way check out all the "fully deserved...well done Graham messages from his connections on Linklden. If you want to see herd immunity in terms of failing people congratulating more failure its there in all its glory. Incredible when they know what he has done to hard working investors money at Motif and failing to get Iclaprim approved they can all be congratulating him. Amazing. Anyway I digress - remember this pearler from 2nd September 2019? If you are in doubt about the total truth of the most recent update about a RTO look at this from the RNS: "We are well prepared for the meeting with the FDA on September 19 to discuss our proposed clinical trial for iclaprim. In addition, we are actively pursuing options to broaden our pipeline as we work to build shareholder value. We appreciate the continued support and flexibility of Hercules and the confidence that they have in our team to deliver on our strategic goals.” GL "Broaden our pipeline" Absolutely laughable stuff and the most outrageous lie of all time. For just 28 days later they were proposing the wind down of everything and becoming a cash shell and needed a cash raise!!!!! How were you planning to "Broaden the pipeline" Graham given that financial backdrop? What investors have had to endure here is beyond reasonable
scottdavid70
14/1/2021
20:58
Liam told you that? No surprise he left as company secretary then to try to make himself invisible to the Armageddon that appears to be finally coming. Was a bit too convenient that they said middle of January for the next update which leaves exactly the right amount of time to NOT be able to call a General Meeting. There isn’t one person from Walbrook Peel Hunt SP Angel Motif That hasn’t let down hard working ordinary investors here. How they sleep knowing what they have said and what has happened is beyond me
scottdavid70
14/1/2021
20:12
10 business days to go Assume they will try to go against what they said about a vote but I am told that legally can’t happen so not sure what their plan is. It’s not supposed to be this way. Make sure you are all ready to act as soon as the news is released to potentially make the board deliver value for you and to look after YOUR interests as is their legal obligation
scottdavid70
13/1/2021
12:50
It was at the AGM he had hurriedly moved ahead of the FDA decision where they were asking for more salaries despite having failed to gain approval!! Incredible stuff It was voted down That was the all bases covered moment
scottdavid70
13/1/2021
09:55
Do you know the date of the video? I've just watched the last three Proactive videos before the FDA response in Feb 2019 (the June 18th 2018, August 8th 2018, August 14th PI videos) and I haven't heard anything like "all bases covered". There don't seem to be any others between August 2018 and May 2019. What he says in the June 18th 2018 video is very interesting though, from 3 minutes onwards.
bi11y ray va1entine
13/1/2021
09:09
Billy - go back and watch the Proactive interview just before the FDA decision came out. He pointedly makes reference to the 3 options and all bases covered. I have watched it so many times You can even look out for the cheeky grin when saying...as we have always said they may ask for more data...when he talks about the 3rd option. Shifty looking smile that isn’t when you watch? Of course he had said the FDA didn’t ask for more clinical trials in the webcast of the 19th Feb 2019 leaving everyone thinking that it was a solvable issue but we ended up with full phase 3 trials!! Funny old world the Complete Response Letter and it’s interpretation isn’t? Look forward to requesting it for my book at the end of this month. Cost a few Bob in court no doubt but we deserve to see what it said don’t we?
scottdavid70
13/1/2021
09:02
12 business days left and the comfort of having Dr Lumsdens promise that he has all bases covered fills me with so much confidence. All bases covered means he is able to protect your investment based on his guidance so that’s great news for us with less time remaining than possible for a General Meeting to be called. What scenario could possibly work out to be bad for investors seriously with that type of guarantee attached to your money??
scottdavid70
13/1/2021
09:01
I'm not sure what you mean by "two out of three of the easier options to approval". As I understood it, the phase 3 trial collected the data the FDA told the board they would want and the trial was successful. But after they applied for approval the FDA moved the goalposts. What were the other options or routes to approval?
bi11y ray va1entine
13/1/2021
08:42
Remember if we do get a last minute vote to call your nominee bank/institution so you can tell them how you want to vote via the proxy form of one is produced. Might be a lastminute.com vote if the deal obliterates shareholders further and potentially enriches this shower further so make sure you can vote to Stoke that happening if nothing else. I am primed and ready with double digit millions of votes to turn the tide of greed into wealth for the righteous hard working ordinary investor who has been lead down a path of financial Armageddon
scottdavid70
13/1/2021
07:16
So the million pence question surrounding this shower of a Board is about to be answered. It’s really very simple: To leave it this late to announce the RTO means it’s either been the most competitive RTO in the history of RTO’s or it’s such a bad deal for existing shareholders they have left it this late so they can say it’s this deal or nothing. Which one does everyone think it is? Any guesses which one I think it is?......
scottdavid70
12/1/2021
16:05
Nope he meant it in the event that Iclaprim wasn’t given 2 out of the 3 easier options to approval that he still had the third base, another trial, covered. As we know that was simply not true
scottdavid70
12/1/2021
10:08
Is there a reason you think the "All bases covered" claim wasn't just an honest mistake? I don't know as much about this as you do. But didn't the company do exactly what the FDA said they should right up until the response?
bi11y ray va1entine
11/1/2021
19:10
Don’t panic at all. Remember DR LUMSDEN and you can always trust a DR said he has “all bases covered” Chill and enjoy the legend that is the Lumsden
scottdavid70
11/1/2021
15:11
The directors will get a share deal.. do think they will want the share price to go down or UP.
petersmith6
11/1/2021
13:32
Some people have the silly idea that this will rise like a Phoenix from the ashes. It will in fact sink like the Titanic, in this case never to be seen or heard from again.
perfectstorm
11/1/2021
10:34
It’s like the guy they are writing about here didn’t decimate Motif shareholders and was a unqualified success. Absolutely remarkable and equally wrong
scottdavid70
11/1/2021
06:22
Are Motif long suffering shareholders going to get the vote they were promised?
scottdavid70
11/1/2021
02:49
There has been an RTO and have been renamed the LSE Inaction Group.
lithological heterogeneities
Chat Pages: 358  357  356  355  354  353  352  351  350  349  348  347  Older
ADVFN Advertorial
Your Recent History
LSE
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210119 07:12:50